Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one, also known as a metabolite of Dipyrone, is a member of the class of pyrazoles that is antipyrine substituted at C-4 by a methylamino group. It is characterized by its pale orange color and low melting point, presenting as a waxy solid. 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one is derived from the metabolism of aminopyrine and metamizole, which are pharmaceutical compounds with analgesic and antipyretic properties.

519-98-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 519-98-2 Structure
  • Basic information

    1. Product Name: 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one
    2. Synonyms: 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one;noramidopyrine;4-(Methylamino)-antipyrine;2,3-Dimethyl-4-methylamino-1-phenyl-3-pyrazolin-5-one;Methylaminoantipyrine;Monomethylaminoantipyrine;Noraminopyrine;3H-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(methylamino)
    3. CAS NO:519-98-2
    4. Molecular Formula: C12H15N3O
    5. Molecular Weight: 217.267
    6. EINECS: 208-281-3
    7. Product Categories: Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals
    8. Mol File: 519-98-2.mol
  • Chemical Properties

    1. Melting Point: 50-53°C
    2. Boiling Point: 324.5°C at 760 mmHg
    3. Flash Point: 150°C
    4. Appearance: /
    5. Density: 1.20±0.1 g/cm3 (20 ºC 760 Torr)
    6. Vapor Pressure: 0.000245mmHg at 25°C
    7. Refractive Index: 1.619
    8. Storage Temp.: -20°C Freezer
    9. Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
    10. PKA: 4.76±0.20(Predicted)
    11. CAS DataBase Reference: 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one(CAS DataBase Reference)
    12. NIST Chemistry Reference: 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one(519-98-2)
    13. EPA Substance Registry System: 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one(519-98-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 519-98-2(Hazardous Substances Data)

519-98-2 Usage

Uses

1. Used in Pharmaceutical Applications:
1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its role in the metabolism of aminopyrine and metamizole suggests potential utility in the development of new drugs with similar therapeutic effects.
2. Used in Research and Development:
In the field of medicinal chemistry, 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one is used as a research compound for [application reason]. Its chemical properties and structural features make it a valuable tool for understanding the mechanisms of action and potential side effects of related drugs, as well as for designing new therapeutic agents.
3. Used in Quality Control and Analysis:
1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3H-pyrazol-3-one is also used as a reference material in the quality control and analysis of pharmaceutical products containing aminopyrine, metamizole, or their derivatives. It helps ensure the purity, potency, and safety of these medications by providing a standard for comparison during testing and quality assurance processes.

Check Digit Verification of cas no

The CAS Registry Mumber 519-98-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 9 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 519-98:
(5*5)+(4*1)+(3*9)+(2*9)+(1*8)=82
82 % 10 = 2
So 519-98-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N3O/c1-9-11(13-2)12(16)15(14(9)3)10-7-5-4-6-8-10/h4-8,13H,1-3H3

519-98-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,5-dimethyl-4-(methylamino)-2-phenylpyrazol-3-one

1.2 Other means of identification

Product number -
Other names 4-(N-methyl)-aminoantipyrine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:519-98-2 SDS

519-98-2Synthetic route

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl-)-N-methyl-carbamidsaeuremethylester
10116-07-1

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl-)-N-methyl-carbamidsaeuremethylester

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With potassium hydroxide at 50℃;94%
4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With 1-butyl-3-methylimidazolium Tetrafluoroborate at 160℃; for 5h; Temperature; Concentration;89%
metamizol
68-89-3

metamizol

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 60℃; for 3h;86.7%
In water for 4h; Irradiation; Yield given;
4-N-acetyl-N-methylaminoantipyrine
15421-74-6

4-N-acetyl-N-methylaminoantipyrine

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With hydrogenchloride; water Reflux;85%
(E)-4-(benzylideneamino)-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one
83-17-0

(E)-4-(benzylideneamino)-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
In dimethyl sulfoxide for 6h; Heating;60%
Metamizol
50567-35-6

Metamizol

A

metamorphine
948017-85-4

metamorphine

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With water; sodium chloride at 37℃; for 1008h; Kinetics;A 50%
B n/a
formaldehyd
50-00-0

formaldehyd

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
Hydrogenation.katalytischen;
N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-phthalamic acid

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-phthalamic acid

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With sulfuric acid; water
aminopyrine
58-15-1

aminopyrine

A

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

C

Rubazonsaeure
1248-55-1

Rubazonsaeure

D

4-hydroxyantipyrine
1672-63-5

4-hydroxyantipyrine

Conditions
ConditionsYield
With oxygen at 15 - 20℃; Mechanism;
metamizol
68-89-3

metamizol

A

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
In water Kinetics; Irradiation; photochemical decomposition, λ=254 nm;
metamizol
68-89-3

metamizol

A

formaldehyd
50-00-0

formaldehyd

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
With sodium hydroxide at 100℃; for 0.5h;
4--antipyrine

4--antipyrine

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
durch Verseifung;
4-bromo-antipyrine

4-bromo-antipyrine

methylamine solution

methylamine solution

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

hydrogenchloride
7647-01-0

hydrogenchloride

water
7732-18-5

water

metamizol
68-89-3

metamizol

A

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

B

aminopyrine
58-15-1

aminopyrine

hydrogenchloride
7647-01-0

hydrogenchloride

water
7732-18-5

water

metamizol
68-89-3

metamizol

A

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

B

1,5,1',5'-tetramethyl-2,2'-diphenyl-1,2,1',2'-tetrahydro-4,4'-(N,N'-dimethyl-N,N'-methanediyl-diamino)-bis-pyrazol-3-one
810-16-2

1,5,1',5'-tetramethyl-2,2'-diphenyl-1,2,1',2'-tetrahydro-4,4'-(N,N'-dimethyl-N,N'-methanediyl-diamino)-bis-pyrazol-3-one

metamizol
68-89-3

metamizol

A

formaldehyd
50-00-0

formaldehyd

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

C

NaHSO3

NaHSO3

Conditions
ConditionsYield
With sodium hydroxide at 100℃; for 0.5h; Mechanism; dependence from temperature;
4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

2-phenyl-cinchoninic acid-chloride

2-phenyl-cinchoninic acid-chloride

A

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

B

N,N-dimethyl-DL-alanine

N,N-dimethyl-DL-alanine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2O; ethanol
2: 60 percent / dimethylsulfoxide / 6 h / Heating
View Scheme
aminopyrine
58-15-1

aminopyrine

A

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

B

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

C

4-(N,N-dimethyl)-4'-hydroxyaminoantipyrine
178937-52-5

4-(N,N-dimethyl)-4'-hydroxyaminoantipyrine

D

4-(N,N-dimethyl)-3'-hydroxyaminoantipyrine
1229026-20-3

4-(N,N-dimethyl)-3'-hydroxyaminoantipyrine

E

4-(N,N-dimethyl)-2'-hydroxyaminoantipyrine
1229026-19-0

4-(N,N-dimethyl)-2'-hydroxyaminoantipyrine

Conditions
ConditionsYield
With ferrous ethylenediamine tetraacetate; dihydrogen peroxide; ascorbic acid pH=7; Fenton reaction; aq. phosphate buffer;
4-acetylaminoantipyrine
83-15-8

4-acetylaminoantipyrine

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran; mineral oil / 0 - 20 °C / Inert atmosphere
2: hydrogenchloride; water / Reflux
View Scheme
4-aminoantipyrine hydrochloride
22198-72-7

4-aminoantipyrine hydrochloride

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: N-ethyl-N,N-diisopropylamine; nickel dichloride / CH3Cl
2: sodium hydride / tetrahydrofuran; mineral oil / 0 - 20 °C / Inert atmosphere
3: hydrogenchloride; water / Reflux
View Scheme
metamizole

metamizole

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Conditions
ConditionsYield
In water at 80℃; for 2h;
formaldehyd
50-00-0

formaldehyd

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Metamizol
50567-35-6

Metamizol

Conditions
ConditionsYield
With sulfur dioxide; water In ethanol at 60 - 80℃; under 2068.65 - 3102.97 Torr; Solvent; Pressure;98.5%
formaldehyd
50-00-0

formaldehyd

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

analgin magnesium

analgin magnesium

Conditions
ConditionsYield
With sulfur dioxide; water; magnesium oxide In isopropyl alcohol at 20 - 80℃; under 1034.32 - 2068.65 Torr; for 3h; Solvent; Reagent/catalyst; Temperature; Pressure;95.5%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Methylaminooxoessigsaeure-2-acetyl-2-methyl-1-phenylhydrazid
92569-10-3

Methylaminooxoessigsaeure-2-acetyl-2-methyl-1-phenylhydrazid

Conditions
ConditionsYield
With oxygen; methylene blue at 20℃; for 4h; Irradiation;94%
With sodium periodate In methanol; water for 24h; Ambient temperature;64%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Eudesmic acid
118-41-2

Eudesmic acid

2,3-Dimethyl-4-(N-methyl-N-3',4',5'-trimethoxybenzoylamino)-1-phenylpyrazol-5-one
67818-78-4

2,3-Dimethyl-4-(N-methyl-N-3',4',5'-trimethoxybenzoylamino)-1-phenylpyrazol-5-one

Conditions
ConditionsYield
With phosphorus pentachloride at 175 - 180℃; for 0.666667h;83.41%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2,3-Dimethyl-4-(N-methyl-N-3',4',5'-trimethoxybenzoylamino)-1-phenylpyrazol-5-one
67818-78-4

2,3-Dimethyl-4-(N-methyl-N-3',4',5'-trimethoxybenzoylamino)-1-phenylpyrazol-5-one

Conditions
ConditionsYield
In diethyl ether; benzene for 5h; Heating;82.38%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

C12H15N3O4S

C12H15N3O4S

Conditions
ConditionsYield
With chlorosulfonic acid In dichloromethane at 10℃; for 15h; Solvent; Temperature;75.2%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

methyl chloroformate
79-22-1

methyl chloroformate

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl-)-N-methyl-carbamidsaeuremethylester
10116-07-1

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl-)-N-methyl-carbamidsaeuremethylester

Conditions
ConditionsYield
With sodium carbonate71.2%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

4-(N-methyl-N-nitroso)aminoantipyrine
73829-38-6

4-(N-methyl-N-nitroso)aminoantipyrine

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite In water at 0℃; for 1h;70%
all cis 5,8,11,14-eicosatetraenoic acid
506-32-1

all cis 5,8,11,14-eicosatetraenoic acid

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

Arachidonoyl-4-methylaminoantipyrin
1115860-30-4

Arachidonoyl-4-methylaminoantipyrin

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 3h;64%
(4-iodophenyl)acetic acid
1798-06-7

(4-iodophenyl)acetic acid

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-(4-iodo-phenyl)-N-methyl-acetamide
81217-13-2

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-(4-iodo-phenyl)-N-methyl-acetamide

Conditions
ConditionsYield
With phosphorus trichloride In benzene Heating;60%
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

α-bromopropionyl bromide
563-76-8

α-bromopropionyl bromide

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]
100974-58-1

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]

Conditions
ConditionsYield
With chloroform; potassium carbonate
phosgene
75-44-5

phosgene

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-carbamoyl chloride
108879-93-2

(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-carbamoyl chloride

Conditions
ConditionsYield
With benzene
formaldehyd
50-00-0

formaldehyd

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

potassium cyanide
151-50-8

potassium cyanide

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-glycine nitrile
92296-21-4

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-glycine nitrile

Conditions
ConditionsYield
With water; acetic acid
formaldehyd
50-00-0

formaldehyd

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

aminopyrine
58-15-1

aminopyrine

Conditions
ConditionsYield
With hydrogenchloride; water; sodium sulfite
With hydrogenchloride
formaldehyd
50-00-0

formaldehyd

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

1,5,1',5'-tetramethyl-2,2'-diphenyl-1,2,1',2'-tetrahydro-4,4'-(N,N'-dimethyl-N,N'-methanediyl-diamino)-bis-pyrazol-3-one
810-16-2

1,5,1',5'-tetramethyl-2,2'-diphenyl-1,2,1',2'-tetrahydro-4,4'-(N,N'-dimethyl-N,N'-methanediyl-diamino)-bis-pyrazol-3-one

2-bromopropionic anhydride
67404-58-4

2-bromopropionic anhydride

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]
100974-58-1

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]

Conditions
ConditionsYield
With benzene
diethylamino-propionic acid
98204-12-7

diethylamino-propionic acid

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

N,N-diethyl-DL-alanine-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide
58965-95-0

N,N-diethyl-DL-alanine-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide

Conditions
ConditionsYield
With phosphorus pentoxide at 160 - 170℃;
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-carbamic acid ethyl ester
10077-99-3

(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-carbamic acid ethyl ester

Conditions
ConditionsYield
With sodium carbonate
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

benzyl bromide
100-39-0

benzyl bromide

4-methylbenzylamino-antipyrine

4-methylbenzylamino-antipyrine

Conditions
ConditionsYield
With benzene
With benzene
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

phenyl isocyanate
103-71-9

phenyl isocyanate

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-N'-phenyl-urea
102082-15-5

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methyl-N'-phenyl-urea

Conditions
ConditionsYield
With chloroform
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

ethyl iodide
75-03-6

ethyl iodide

4-methylethylamino-antipyrine

4-methylethylamino-antipyrine

4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

allyl bromide
106-95-6

allyl bromide

4-(allyl-methyl-amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one

4-(allyl-methyl-amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one

Conditions
ConditionsYield
With benzene at 100℃;
4-methylaminoantipyrine
519-98-2

4-methylaminoantipyrine

2-Bromopropionic acid
598-72-1

2-Bromopropionic acid

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]
100974-58-1

2-bromo-propionic acid-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-methyl-amide]

Conditions
ConditionsYield
With phosphorus pentoxide

519-98-2Relevant articles and documents

Electrochemical behaviour of dipyrone (metamizole) and others pyrazolones

Bacil, Raphael P.,Buoro, Rafael M.,Campos, Othon S.,Ramos, Matesa A.,Sanz, Caroline G.,Serrano, Silvia H.P.

, p. 358 - 366 (2018)

The electrochemical oxidation of dipyrone (MTM) in aqueous medium was characterized using antipyrine (AA), 4-aminoantipyrine (4AA), 4-methyl-aminoantipyrine (MAA) and 4-dimethyl-aminoantipyrine (DMAA) as model molecules for the elucidation of all MTM voltammetric signals. The MTM and the other pyrazolones show up to four oxidation electrochemical processes. The voltammograms obtained in AA solutions presented an irreversible electrochemical oxidation process involving one electron at Eap3, which is common to all pyrazolone derivatives, while the amino pyrazolones present electrochemical oxidation processes at Eap0 or Eap1. The stabilization of the oxidation products depends on different effects: the proton release added to the thermodynamic stability, in the case of the imine formation at Eap0 (4AA and MAA) and the hyperconjugation (σ-stabilization) in the case of iminium formation (DMAA and MTM) at Eap1. The process observed at Epa0 corresponds to the pH-dependent oxidation of the primary and secondary enamines, while the process observed at Eap1 occurs in the tertiary enamines, is pH independent. The oxidation peak potential follows the order: MAA a linear range from 10 μmol L?1 to 100 μmol L?1 with a LOD of 1.94 and 2.97 μM for DMAA and MTM, respectively, LOQ of 6.48 and 9.91 μM (n = 10) and, sensitivity of 0.96 μA/μM for DMAA and 0.92 μA/μM; with a recoveries of 95–105% for MTM.

Preparation method of 4-methylaminoantipyrine

-

Paragraph 0015, (2016/11/28)

The invention discloses a preparation method of 4-methylaminoantipyrine. The preparation method consists of: taking aminoantipyrene shown as formula (I) as the raw material, in a 1-methyl-3-butylimidazolium tetrafluoroborate ionic liquid reaction medium, and under the action of solid alkali, carrying out dimethyl carbonate methylation one-step reaction to obtain 4-methylaminoantipyrine shown as formula (II). The reaction equation is shown as the specification, and the solid alkali is macroporous weakly basic styrene type anion exchange resin. The technology has the characteristics of easy operation and high product purity, is a new synthetic technical route, and has the advantages of safety and easily available raw materials, thus being conducive to industrial production.

Antinociceptive activity of metamizol metabolites in a rat model of arthritic pain

Lopez-Munoz, Francisco Javier,Soria-Arteche, Olivia,Lopez, Jose Raul Medina,Hurtado Y De La Pena, Marcela,Garcia, Ma. Concepcion Lozada,Moreno-Rocha, Luis Alfonso,Dominguez-Ramirez, Adriana Miriam

, p. 332 - 338 (2013/08/23)

Preclinical Research The aim of the present study was to evaluate the antinociceptive activity of the main metamizol (MET) metabolites, 4-methylaminoantipyrine (MAA), 4-aminoantipyrine (AA), 4-formylaminoantipyrine (FAA), and 4-acetylaminoantipyrine (AAA) using the "pain-induced functional impairment in rat" model (PIFIR model). The antinociceptive efficacies of MAA and AA were 288.3% h and 281.1% h, respectively, close to the efficacy of MET (333.80% h). The effective dose to attain 50% of the maximum response (ED50) values for MET, MAA and AA were 126.1, 124.9, and 110.7 mg/kg, respectively. FAA and AAA were essentially inactive in this experimental model. Part of the antinociceptive effect showed by MET in this study might be attributed to the effect of the metabolites MAA and AA on cyclooxygenases COX-1 and COX-2 activity.

NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation

Roberts, Arthur G.,Sjoegren, Sara E. A.,Fomina, Nadezda,Vu, Kathy T.,Almutairi, Adah,Halpert, James R.

experimental part, p. 2123 - 2134 (2012/03/10)

To understand the molecular basis of sequential N-dealkylation by cytochrome P450 2B enzymes, we studied the binding of amidopyrine (AP) as well as the metabolites of this reaction, desmethylamidopyrine (DMAP) and aminoantipyrine (AAP), using the X-ray crystal structure of rabbit P450 2B4 and two nuclear magnetic resonance (NMR) techniques: saturation transfer difference (STD) spectroscopy and longitudinal (T1) relaxation NMR. Results of STD NMR of AP and its metabolites bound to P450 2B4 were similar, suggesting that they occupy similar niches within the enzyme's active site. The model-dependent relaxation rates (RM) determined from T1 relaxation NMR of AP and DMAP suggest that the N-linked methyl is closest to the heme. To determine the orientation(s) of AP and its metabolites within the P450 2B4 active site, we used distances calculated from the relaxation rates to constrain the metabolites to the X-ray crystal structure of P450 2B4. Simulated annealing of the complex revealed that the metabolites do indeed occupy similar hydrophobic pockets within the active site, while the N-linked methyls are free to rotate between two binding modes. From these bound structures, a model of N-demethylation in which the N-linked methyl functional groups rotate between catalytic and noncatalytic positions was developed. This study is the first to provide a structural model of a drug and its metabolites complexed to a cytochrome P450 based on NMR and to provide a structural mechanism for how a drug can undergo sequential oxidations without unbinding. The rotation of the amide functional group might represent a common structural mechanism for N-dealkylation reactions for other drugs such as the local anesthetic lidocaine.

Scavenging activity of aminoantipyrines against hydroxyl radical

Santos, Pedro M.P.,Antunes, Alexandra M.M.,Noronha, Jo?o,Fernandes, Eduarda,Vieira, Abel J.S.C.

experimental part, p. 2258 - 2264 (2010/06/19)

The pyrazolone derivatives antipyrine and 4-(N,N-dimethyl)-aminoantipyrine (aminopyrine) have long been used as analgesic, antipyretic and anti-inflammatory drugs. However, in spite of its recognized therapeutic benefits, the use of pyrazolones has been associated with agranulocytosis. Though the oxidation of aminopyrine by neutrophil-generated hypochlorous acid (HOCl), leading to the formation of a cation radical, has been considered responsible for the potential bone marrow toxicity, the reaction mechanisms of pyrazolones against other reactive oxygen species (ROS) remains elusive. Thus, the reactions of 4-aminoantipyrine and methylated derivatives with hydroxyl radicals (HO?) were studied as a model of their reactivity against ROS. The results show that 4-(N,N-dimethyl)-aminoantipyrine (aminopyrine) undergoes demethylation when reacting with HO· radical, leading to 4-(N-methyl)-aminoantipyrine, which is further demethylated to 4-aminoantipyrine. In addition, it was also observed that another favorable reaction of 4-aminoantipyrines in these conditions is the hydroxylation on the aromatic ring, a reaction that is common to aminopyrine, 4-(N-methyl)-aminoantipyrine, and 4-aminoantipyrine. Whether these reaction mechanisms give rise to harmful reactive intermediates requires further chemico-biological evaluation.

MORPHINE COMPOUNDS FOR PHARMACEUTICAL COMPOSITIONS

-

Page/Page column title page; 4; sheet 1; sheet 2, (2009/01/23)

The invention relates to new morphine compounds of the formula: where R1 represents a C1-6 alkyl radical and the radicals R2 and R3 are independently selected from the group consisting of hydrogen atoms, methyl groups and acetyl groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 519-98-2